Oxolife’s CEO Agnès Arbat receives prestigious EU Women Innovators Prize
Barcelona, Spain – 9 April 2025: Oxolife, the female fertility biotech focused on increasing live birth rates by enhancing embryo implantation in women undergoing assisted reproductive technology (ART) fertility treatment, today announces that Agnès Arbat, its Chief Executive Officer, has been awarded the prestigious EU Women Innovators Prize at the European Innovation Council (EIC) Summit on the 3rd of April 2025 in Brussels, Belgium.
